Dr. Dmytro Mozhynskyy, General Director of GCT in Ukraine took part in the sixth international scientific conference “Clinical Trials of Drugs in Ukraine: New Challenges and Responses to Them” in Kyiv. It was a two-day event, which was organized and held partially online with brief in-person visits.
At the conference, the issues and changes in regulatory framework, organization and conduct of clinical trials were raised and discussed. The industry professionals also focused on quality control and use of electronic resources in clinical trials.
Updated: October 21, 2020
GCT President, Dr. Jeffrey Apter is participating at the 13th Clinical Trials on Alzheimer’s Disease Congress (CTAD) which is held from 4th to 7th of November.
The congress brings worldwide leaders in the treatment of Alzheimer’s disease together, and is a perfect platform to share their expertise in the research of Alzheimer’s disease. Dr. Apter is KOL in psychiatry and has over 30 years of experience in clinical research focusing on Alzheimer’s disease.
Reach out to us at bd@gctrials.com if you would like to set up a meeting.
Updated: October 21, 2020
This Monday, October 19th GCT started the participation at the World Vaccine Congress Europe 2020.
Aleksandr Stiblo, Director of Business Development, is representing GCT in face-to-face meetings, panel discussions, round tables and keynote presentations.
Join us at the congress to find out more about conducting clinical trials.
If you would like to set up a meeting or have any questions, please reach out to us at bd@gctrials.com.
Updated: October 19, 2020
October is Breast Cancer Awareness Month (BCAM). Breast Cancer is the most common type of cancer among women.
This month people all over the world show their support for individuals affected by breast cancer. The number of BCA campaigns increases each year proving more help and information to patients and caregivers.
GCT has a vast experience conducting oncology clinical research. Recently, we have initiated a Phase I Breast Cancer study to assess the efficacy, tolerance and PK parameters of the investigational product designed to treat Breast Cancer in Women.
We are grateful to have the opportunity to make our own contribution to the common cause.
Updated: October 16, 2020
Last sunny Saturday, our Junior Clinical Research Associate in Russia, Elizaveta Karkacheva, celebrated her birthday.
Elizaveta has recently joined GCT, and during the 4 months at the company she has become a valuable part of our team.
We wish you all the best in the next year, and hope all your dreams come true!
Updated: October 12, 2020
Every 10th of October is World Mental Health Day.
The awareness day was observed over the last weekend in order to raise awareness of various mental health conditions and help people realize the importance of their mental health.
Updated: October 12, 2020
October 8th is World Sight Day, an awareness day held annually to bring attention to eye diseases that lead to blindness or vision impairment.
The causes of vision loss can vary from diabetes to cataract and glaucoma. One thing in common – early diagnosis helps reduce the symptoms, slow the progression of the condition or even return to normal vision.
GCT focuses on Ophthalmology clinical trials and is an exclusive information partner for the White Nights annual ophthalmology congress taking place in St. Petersburg, Russia. We look forward to further participation in promoting and conducting research in this therapeutic area.
Updated: October 8, 2020
Despite of COVID-19 challenging the routine of clinical trials worldwide, Global Clinical Trials has successfully randomized the first patient into a clinical trial evaluating the efficacy of IP in the sore throat pain relief.
This is a phase IV, multicenter, randomized, non-inferiority trial aiming to enroll over 300 patients globally.
The first patient was enrolled only 4 days after the site activation.
“We are honored to manage this clinical program in Russia and to be able to deliver FPI shortly after site initiation. At the same time, keeping patients, site and GCT staff safe is our ultimate focus. We are hoping the trial will be a success and will improve treatment options for patients in Eastern Europe,” said Eugene Selivra, MD, CEO of Global Clinical Trials.
Updated: October 8, 2020
Yesterday Global Clinical Trials started its participation at #CPhI 2020, which is held virtually from 6th to 15th of October. This allows the participants to join the Festival of Pharma from any location safely.
GCT is excited to take part in such a large-scale event, meeting the industry professionals and sharing our experience and expertise.
We are open for meetings at CPhI 2020 – please contact us at bd@gctrials.com to set up a call with Aleksandr Stiblo, Director of Business Development.
Updated: October 7, 2020
September was full of events for the pharma and biotech community.
GCT President, Dr. Jeffrey Apter, participated at the annual Autumn conference organized by the International Society for CNS Clinical Trials and Methology (ISCTM).
From 21 to 25 of September professionals all over the world took part virtually in the #ISCTM2020. The topics addressing clinical, regulatory, methodological and policy challenges in CNS clinical trials were among the many discussed.
GCT is a global CRO focused on CNS and Neurology clinical trials, and on the market since 2001. Dr. Jeffrey Apter, GCT president is the Key Opinion Leader in psychiatry specializing in Alzheimer’s disease and Depression research. Should you have any questions or require information about clinical trials, please contact us at bd@gctrials.com
Updated: October 2, 2020
GCT is taking part in CPHI 2020, Festival of Pharma. The virtual program will take place 5-16 of October.
CPHI 2020 brings together thousands of professional pharmaceutical industry attendees for 10 days full of gripping content and networking opportunities.
Despite all the pandemic challenges, GCT is always seeking for new development opportunities. Aleksandr Stiblo, Business development Director, will be happy to meet you at CPHI 2020 and answer any questions. If you would like to set up a meeting, please get in touch with us at bd@gctrial.com.
Updated: September 30, 2020
September is World Alzheimer’s Month. The purpose of this campaign is to raise awareness and challenge the stigma that surrounds dementia.
Some of the symptoms of this brain disease include:
- slowed thinking
- occasional or persistent memory problems
- disorientation
- unexpected mood and behavior changes
- confusion about events, time and place
- difficulty speaking, swallowing and walking
Both GCT President, Dr. Jeffrey Apter and CEO, Dr. Eugene Selivra are trained psychiatrists with 50+ years of combined experience in clinical research. Dr. Apter is a KOL in Alzheimer’s Disease. For more than 19 years GCT has been focusing on conducting trials in CNS and Neurology, including the Alzheimer’s Disease indication.
Patients with Alzheimer’s disease may find it hard to recognize the problem. Nevertheless, we can assist through raising awareness.
Updated: September 29, 2020
Yesterday our IT Director, Alexey Lobanov, celebrated his birthday.
All of us at GCT are grateful to have such a professional and devoted colleague. Alexey has been with GCT for over 15 years now and become an irreplaceable part of the team.
We wish Alexey a lot of happiness and success, and a memorable year ahead!
Updated: September 28, 2020
September is Blood Cancer Awareness Month (BCAM). This is a wonderful opportunity to support people fighting leukemia, lymphoma, myeloma, and other types of blood cancer.
Blood cancer occurs when the normal blood cell development process is interrupted by uncontrolled growth of an abnormal type of blood cell. These abnormal blood cells prevent blood from performing many of its functions, like fighting off infections or preventing serious bleeding.
As over 900,000 people worldwide are diagnosed with various types of blood cancer annually, it is crucial to share support and spread awareness of this group of diseases.
Updated: September 23, 2020
September presents an opportunity to become more aware of the life threatening arrhythmia. National Atrial Fibrillation (AFib) Awareness Month is organized by Heart Rhythm Society to and held every September in order to raise awareness of this common but critical condition.
Having AFib poses a greater risk of stroke. Some of the common symptoms of AFib include irregular heartbeat, shortness of breath, and unusual fatigue. It is crucial to get diagnosed, if any of these symptoms show.
Many treatment options are available to those diagnosed with the condition, including medication, surgery, cardioversion and catheter ablation.
Updated: September 18, 2020
Celebrating World Patient Safety Day today and expressing gratitude to those ensuring well-being and safety of patients everyday worldwide!
Updated: September 17, 2020
September is Childhood Cancer Awareness Month (CCAM). CCAM is held every year by childhood cancer organizations which strive to increase awareness and raise funds for pediatric cancer research.
GCT is an oncology focused CRO with extensive expertise conducting clinical trials in various types of cancer. Let’s use this opportunity to help spread awareness of Childhood Cancer.
Updated: September 16, 2020
Today GCT global team is wishing a Happy Birthday to Anna Tkachenko, GCT Chief Accountant in Russia! Starting out as an accountant, Anna has been working at GCT for over 6 years now.
We would like to thank Anna for her endless enthusiasm and positive attitude. GCT wishes Anna many new memories and achievements in the new year!
Updated: September 15, 2020
Today we are wishing a Happy Birthday to Dr. Umakanta Sahoo, GCT Managing Director in India!
Dr. Sahoo is a valuable part of our team since 2017. His competence, experience within the industry and leadership skills make us really grateful to have Umakanta within the Team.
May all your dreams come true! Happy Birthday!
Updated: September 9, 2020
GCT team is proud of taking part in the achievement of the major milestone for the Phase III clinical trial. The study is being successfully conducted, amidst the present difficult global environment, in pediatric patients suffering from a rare neurological disease. It is a randomized, double-blind, placebo-controlled trial followed by a long-term open label treatment. In January 2020, GCT successfully completed the enrollment of patients in Russia. We have now reached the next milestone – the Database Lock.
Despite all the challenges caused by the pandemic, the GCT team was able to follow each patient closely and ensure they complete all the required assessments, keeping trial participants safe during the treatment stage. This trial required a high level of GCT expertise and involvement, which the team successfully delivered.
“The sponsor of this trial, a US Pharmaceutical company, demonstrated an incredible level of trust in GCT, for which we are extremely grateful. We hope that our professional relationship will continue to grow and develop in the future,” – Dr. Eugene Selivra, GCT CEO.
Updated: September 7, 2020
